Table 3 Inequality and inequity in spending on hospital, general practitioners, specialists, and pharmaceuticals at end-of-life
| Â | Total Population | |
|---|---|---|
| Â | Inequality (CI) | Inequity (HI) |
Hospital | 0.017 | -0.031 |
General practitioner | 0.017 | -0.006 |
Specialist physician | 0.078 | 0.024 |
Prescription drugs | 0.044 | 0.033 |
| Â | Females | |
| Â | Inequality (CI) | Inequity (HI) |
Hospital | 0.006 | -0.028 |
General Practitioner | 0.009 | -0.006 |
Specialist physician | 0.062 | 0.022 |
Prescription drugs | 0.040 | 0.020 |
| Â | Males | |
| Â | Inequality (CI) | Inequity (HI) |
Hospital | 0.002 | -0.031 |
General practitioner | 0.015 | -0.008 |
Specialist physician | 0.057 | 0.030 |
Prescription drugs | 0.065 | 0.055 |